Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)

Domingos,Hamilton; Cunha,Rivaldo Venâncio da; Paniago,Anamaria Mello Miranda

Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)

Antiretroviral therapy has been associated with hyperlipidemia in AIDS patients. This case illustrates the classic metabolic effects associated to the HAART including protease inhibitors and/or stavudine. It was showed that the management of the HAART-associated dyslipidaemia with conventional antihyperlipidemic therapy may fail, being the switching strategy the best option.

Saved in:

Bibliographic Details
Main Authors:	Domingos,Hamilton, Cunha,Rivaldo Venâncio da, Paniago,Anamaria Mello Miranda
Format:	Digital revista
Language:	English
Published:	Brazilian Society of Infectious Diseases 2007
Online Access:	http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702007000200025
Tags:	Add Tag No Tags, Be the first to tag this record!

id	oai:scielo:S1413-86702007000200025
record_format	ojs
spelling	oai:scielo:S1413-867020070002000252007-06-27Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)Domingos,HamiltonCunha,Rivaldo Venâncio daPaniago,Anamaria Mello Miranda AIDS dyslipidaemia switching strategy Antiretroviral therapy has been associated with hyperlipidemia in AIDS patients. This case illustrates the classic metabolic effects associated to the HAART including protease inhibitors and/or stavudine. It was showed that the management of the HAART-associated dyslipidaemia with conventional antihyperlipidemic therapy may fail, being the switching strategy the best option.info:eu-repo/semantics/openAccessBrazilian Society of Infectious DiseasesBrazilian Journal of Infectious Diseases v.11 n.2 20072007-04-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702007000200025en10.1590/S1413-86702007000200025
institution	SCIELO
collection	OJS
country	Brasil
countrycode	BR
component	Revista
access	En linea
databasecode	rev-scielo-br
tag	revista
region	America del Sur
libraryname	SciELO
language	English
format	Digital
author	Domingos,Hamilton Cunha,Rivaldo Venâncio da Paniago,Anamaria Mello Miranda
spellingShingle	Domingos,Hamilton Cunha,Rivaldo Venâncio da Paniago,Anamaria Mello Miranda Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)
author_facet	Domingos,Hamilton Cunha,Rivaldo Venâncio da Paniago,Anamaria Mello Miranda
author_sort	Domingos,Hamilton
title	Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)
title_short	Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)
title_full	Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)
title_fullStr	Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)
title_full_unstemmed	Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)
title_sort	dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)
description	Antiretroviral therapy has been associated with hyperlipidemia in AIDS patients. This case illustrates the classic metabolic effects associated to the HAART including protease inhibitors and/or stavudine. It was showed that the management of the HAART-associated dyslipidaemia with conventional antihyperlipidemic therapy may fail, being the switching strategy the best option.
publisher	Brazilian Society of Infectious Diseases
publishDate	2007
url	http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702007000200025
work_keys_str_mv	AT domingoshamilton dyslipidaemiaassociatedwiththehighlyactiveantiretroviraltherapyinaidspatientreversionafterswitchingstavudinetotenofovirandlopinavirritonavirtoatazanavirritonavir AT cunharivaldovenancioda dyslipidaemiaassociatedwiththehighlyactiveantiretroviraltherapyinaidspatientreversionafterswitchingstavudinetotenofovirandlopinavirritonavirtoatazanavirritonavir AT paniagoanamariamellomiranda dyslipidaemiaassociatedwiththehighlyactiveantiretroviraltherapyinaidspatientreversionafterswitchingstavudinetotenofovirandlopinavirritonavirtoatazanavirritonavir
_version_	1756416356830412800

Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)

Similar Items

Resource Map